Please login to the form below

Not currently logged in
Email:
Password:

Truberzi

This page shows the latest Truberzi news and features for those working in and with pharma, biotech and healthcare.

NICE backs Allergan's IBS therapy Truberzi

NICE backs Allergan's IBS therapy Truberzi

NICE backs Allergan's IBS therapy Truberzi. The £3 per day therapy was recommended in final guidance from the cost-effectiveness watchdog. ... For doctors to now be able to prescribe Truberzi, a targeted treatment, this will signify real change for

Latest news

  • HIV prevention pill heads July CHMP recommendations HIV prevention pill heads July CHMP recommendations

    Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics